HEXO Corp. (HEXO)
Last Price: 
HEXO Corp. is a consumer-packaged goods cannabis company. It creates and distributes products to serve the global cannabis market. HEXO Corp. is based in GATINEAU, Quebec.
| Revenue (Most Recent Fiscal Year) | $60.46M |
| Net Income (Most Recent Fiscal Year) | $-406.37M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 2.94 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.49 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -179.02% |
| Net Margin (Trailing 12 Months) | -189.28% |
| Return on Equity (Trailing 12 Months) | -12.50% |
| Return on Assets (Trailing 12 Months) | -9.96% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.61 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.11 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.10 |
| Inventory Turnover (Trailing 12 Months) | 1.09 |
| Book Value per Share (Most Recent Fiscal Quarter) | $3.43 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.12 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.96 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.51 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 152.73M |
| Free Float | -- |
| Market Capitalization | $253.52M |
| Average Volume (Last 20 Days) | 7.30M |
| Beta (Past 60 Months) | 1.13 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | 23.31% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |